Bitget App
Trade smarter
Buy cryptoMarketsTradeFuturesStocksEarnInstitutionAI & More
Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

Asian Equities Traded in the US as American Depositary Receipts Decline in Tuesday Trading

MT newswireMT newswire2026/09/08 14:34
10:34 AM EDT, 09/08/2026 (MT Newswires) -- Asian equities traded in the US as American depositary receipts opened the shortened trading week lower Tuesday morning, declining 0.31% to 3,020.55 on the S&P Asia 50 ADR Index. From North Asia, the gainers were led by education company 17 Education & Technology Group (YQ) and semiconductor company ASE Technology (ASX), which surged 20% and 5.9%, respectively. They were followed by utilities company Korea Electric Power (KEP) and internet and data center services provider VNET Group (VNET), which rose 5.4% and 5.6%, respectively. The decliners from North Asia were led by healthcare platform 111 (YI) and tech company Baidu (BIDU), which shed 22% and 8%, respectively. They were followed by automotive company Honda Motor (HMC) and online game developer The9 (NCTY), which dropped 3.8% and 3.4%, respectively. From South Asia, the only gainers were telecommunications company Telekomunikasi Indonesia (TLK) and tech conglomerate Sea (SE), which were up 1.3% and 0.2%, respectively. The decliners from South Asia were led by computer hardware maker Canaan (CAN) and IT firm Infosys INFY), which fell 7.1% and 4.4%, respectively. They were followed by IT firms Wipro (WIT) and Sify Technologies (SIFY), which were down 3.6% and 1.7%, respectively.
0
0

Disclaimer: The content of this article solely reflects the author's opinion and does not represent the platform in any capacity. This article is not intended to serve as a reference for making investment decisions.

Understand the market, then trade.
Bitget offers one-stop trading for cryptocurrencies, stocks, and gold.
Trade now!

You may also like

A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Amgen's Imdelltra has maintained data with an HR of 0.42, nearly doubling survival time. Morgan Stanley estimates that it will become a single product with annual sales of around 5 billions USD. However, they maintain a Neutral rating and a target price of 350 USD.

智通财经•2026/10/26 04:20
A $5 billion single-product emerges? JPMorgan maintains a "Neutral" rating on Amgen (AMGN.US): A good drug doesn't necessarily mean a good buying opportunity.

Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks

Goldman Sachs stated that the Japanese yen has become a better tool for hedging against AI shocks, with policy shifts reducing the risk of depreciation. The bank recommends shorting USD/JPY and EUR/JPY.

智通财经•2026/10/26 03:41
Goldman Sachs: Yen Regains "Safe Haven King" Status, Becomes Most Effective Tool to Hedge Against AI Market Shocks